FITB
36
-3
ADSK
61
4
LOW
39
5
MCO
68
4
CNX
49
7
AMGN
33
-3
VMC
33
3
NDAQ
50
4
GRMN
52
6
VRTX
49
3
FCX
40
5
RCL
64
3
ADI
62
5
CHRW
57
-3
HAL
36
-7
MCK
56
3
COF
47
-2
MDT
64
8
AIZ
52
2
ITW
33
2
FITB
36
-3
ADSK
61
4
LOW
39
5
MCO
68
4
CNX
49
7
AMGN
33
-3
VMC
33
3
NDAQ
50
4
GRMN
52
6
VRTX
49
3
FCX
40
5
RCL
64
3
ADI
62
5
CHRW
57
-3
HAL
36
-7
MCK
56
3
COF
47
-2
MDT
64
8
AIZ
52
2
ITW
33
2
Financhill
Back

Brompton Flaherty & Crumrine Inv Gd Preferred ETF Vs. Janux Therapeutics Industry Stock Comparison

Sell
27

BPRF.TO
Brompton Flaherty & Crumrine Inv Gd Preferred ETF

Last Price:
$22.82
Seasonality Move:
-4.55%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
27
Brompton Flaherty & Crumrine Inv Gd Preferred ETF (BPRF.TO) is a Sell

Is Brompton Flaherty & Crumrine Inv Gd Preferred ETF a Buy, Sell or Hold?

  • The current Brompton Flaherty & Crumrine Inv Gd Preferred ETF [BPRF.TO] share price is $22.79. The Score for BPRF.TO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • BPRF.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPRF.TO Stock Price Chart

What is Brompton Flaherty & Crumrine Inv Gd Preferred ETF's stock price today?

  • The Brompton Flaherty & Crumrine Inv Gd Preferred ETF share price today is $22.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPRF.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

BPRF.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 38.94 Sell
Chaikin Money Flow: 500 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.91 - 23.13) Sell
Bollinger Bands (100): (22.86 - 23.16) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

BPRF.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.92 Sell
20-day SMA: 23.01 Sell
50-day SMA: 23.04 Sell
200-day SMA: 22.74 Buy
8-day EMA: 22.9 Sell
20-day EMA: 22.97 Sell
50-day EMA: 23.01 Sell
200-day EMA: 22.72 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Brompton Flaherty & Crumrine Inv Gd Preferred ETF Earnings Growth & BPRF.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Brompton Flaherty & Crumrine Inv Gd Preferred ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):